A Double-Blind Randomised Placebo-controlled Phase IIb Clinical Trial to Study the Efficacy & Safety of a Novel Platelet Lysate Gel in the Treatment of Lateral Epicondylitis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Platelet-lysate-based-cell-therapy-Celixir (Primary)
 - Indications Tennis elbow
 - Focus Adverse reactions; Therapeutic Use
 - Sponsors Celixir
 
Most Recent Events
- 13 Jun 2017 New trial record
 - 30 Jun 2015 Accordign to the Celixir media release, the endpoints, Improvement in tendon injury, assessed with DASH (Disabilities of the Arm, Shoulder and Hand) PRTEE (Patient-Rated Tennis Elbow Evaluation) has been met.